Systematic Assessment of Patients With Unexplained Cardiac Arrest
Top Cited Papers
- 28 July 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 120 (4), 278-285
- https://doi.org/10.1161/circulationaha.109.853143
Abstract
Background— Cardiac arrest without evident cardiac disease may be caused by subclinical genetic conditions. Provocative testing to unmask a phenotype is often necessary to detect primary electrical disease, direct genetic testing, and perform family screening. Methods and Results— Patients with apparently unexplained cardiac arrest and no evident cardiac disease (normal cardiac function on echocardiogram, no evidence of coronary artery disease, and a normal ECG) underwent systematic evaluation that included cardiac magnetic resonance imaging, signal-averaged ECG, exercise testing, drug challenge, and selective electrophysiological testing. Diagnostic criteria were based on accepted criteria or provocation of the characteristic clinical features for long-QT syndrome, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, early repolarization, arrhythmogenic right ventricular cardiomyopathy, coronary spasm, and myocarditis. Sixty-three patients in 9 centers were enrolled (age 43.0±13.4 years, 29 women). A diagnosis was obtained in 35 patients (56%): Long-QT syndrome in 8, catecholaminergic polymorphic ventricular tachycardia in 8, arrhythmogenic right ventricular cardiomyopathy in 6, early repolarization in 5, coronary spasm in 4, Brugada syndrome in 3, and myocarditis in 1. Targeted genetic testing demonstrated evidence of causative mutations in 9 (47%) of 19 patients. Screening of 64 family members of these patients identified 15 affected individuals who were treated (24%). The remaining 28 patients (44%) were considered to have idiopathic ventricular fibrillation. Conclusions— Systematic clinical testing, including drug provocation and advanced imaging, results in unmasking of the cause of apparently unexplained cardiac arrest in >50% of patients. This approach assists in directing genetic testing to diagnose genetically mediated arrhythmia syndromes, which results in successful family screening.This publication has 41 references indexed in Scilit:
- Diagnostic Value of Endomyocardial Biopsy Guided by Electroanatomic Voltage Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaJournal of Cardiovascular Electrophysiology, 2008
- Long-term cardiac events in men and women with angina at rest and transient ST segment elevationHeart, 2007
- Concordance Between an Electroanatomic Mapping System and Cardiac MRI in Arrhythmogenic Right Ventricular CardiomyopathyPacing and Clinical Electrophysiology, 2006
- Burst bicycle exercise facilitates diagnosis of latent long QT syndromeAmerican Heart Journal, 2005
- Diagnosis of Unexplained Cardiac ArrestCirculation, 2005
- Epinephrine-induced T-wave notching in congenital long QT syndromeHeart Rhythm, 2005
- ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antirrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)Journal of Cardiovascular Electrophysiology, 2002
- ST Segment Elevation in the Right Precordial Leads Induced with Class IC Antiarrhythmic DrugsJournal of Cardiovascular Electrophysiology, 1999
- Influence of the Genotype on the Clinical Course of the Long-QT SyndromeThe New England Journal of Medicine, 1998
- The Value of Electrophysiologic Testing in Patients Resuscitated From Documented Ventricular FibrillationJournal of Cardiovascular Electrophysiology, 1994